ANI Pharmaceuticals, Inc.

Good day, everyone, and welcome to ANI Pharmaceuticals' third quarter 2021 earning results call. At this time, all participants are in a listen-only mode. Later, you will have an opportunity to ask questions during the question-answer session. You may register to ask a question at any time by pressing star and 1 on your touch-tone phone. I will be standing by should you need any assistance. Please note, this call is being recorded. It is now my pleasure to turn the program over to Lisa Wilson.

Thank you, Emma. Welcome to ANI Pharmaceuticals Q3 2021 Earnings Results Call. This is Lisa Wilson, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer of ANI. You can also access the webcast of this call through the Investors section of the ANI website at ANIFarmaceuticals.com. Before we get started, I would like to remind everyone that any statement made on today's conference call that expresses a belief, expectation, projection, forecast, anticipation, or intent regarding future events and the company's future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to ANI Pharmaceuticals Management as of today and involve risks and uncertainties including those noted in our press release issued this morning and our filings with the SEC. Such forward-looking statements are not guarantees of future performance. Actual results may differ materially from those projected in the forward-looking statements. ANI specifically disclaims any intent or obligation to update these forward-looking statements except as required by law. The archived webcast will be available for 30 days on our website, anifarmaceuticals.com. For the benefit of those who may be listening to the replay or archived webcast, this call was held and recorded on November 1st, 2021. Since then, ANI may have made announcements related to the topics discussed, so please reference the company's most recent press releases at SEC Filings. And with that, I'll turn the call over to Nikhil Lalwani.

Thank you, Lisa.